| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.684 | 0 | 9.967 | 9.971 | 10.686 | 8.741 | 8.052 | 7.969 | 7.880 | 7.736 |
| Total Income - EUR | 9.684 | 0 | 9.967 | 9.972 | 10.687 | 8.741 | 8.052 | 7.969 | 7.881 | 7.736 |
| Total Expenses - EUR | 4.588 | 0 | 3.156 | 7.667 | 3.647 | 3.368 | 3.255 | 3.846 | 4.612 | 2.862 |
| Gross Profit/Loss - EUR | 5.097 | 0 | 6.811 | 2.305 | 7.040 | 5.373 | 4.797 | 4.123 | 3.269 | 4.874 |
| Net Profit/Loss - EUR | 4.806 | 0 | 6.512 | 2.205 | 6.719 | 5.132 | 4.584 | 3.882 | 2.716 | 4.084 |
| Employees | 1 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Livpromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 773 | 0 | 248 | 184 | 122 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 31.084 | 0 | 8.178 | 10.616 | 12.420 | 17.643 | 21.816 | 25.895 | 10.149 | 13.840 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 180 | 0 | 153 | 172 | 421 | 62 | 61 | 251 | 311 | 3.619 |
| Cash | 30.904 | 0 | 8.025 | 10.444 | 11.999 | 17.581 | 21.755 | 25.644 | 9.838 | 10.222 |
| Shareholders Funds | 31.640 | 0 | 8.112 | 10.168 | 12.476 | 17.372 | 21.571 | 6.864 | 9.559 | 13.589 |
| Social Capital | 45 | 0 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 218 | 0 | 313 | 631 | 66 | 272 | 246 | 19.031 | 590 | 251 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Livpromed Srl